Tiantian Zhang

Tianjin Key Laboratory Of Molecular Drug Research
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Correction: Li et al. Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules 2023, 28, 6035.

Correction: Li et al. Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules 2023, 28, 6035.

Journal: Molecules (Basel, Switzerland)

Published: April 17, 2026

Geometry-Driven Spin-State Switching in Stacked Phenalenyl Dimers.

Geometry-Driven Spin-State Switching in Stacked Phenalenyl Dimers.

Journal: The journal of physical chemistry. A

Published: January 08, 2026

Correction: Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Correction: Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 23, 2025

Author Correction: Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Author Correction: Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Journal: Scientific reports

Published: July 28, 2025

Corrigendum to "Baricitinib alleviates cardiac fibrosis and inflammation induced by chronic sympathetic activation" [Int. Immunopharmacol. 140 (2024) 112894].

Corrigendum to "Baricitinib alleviates cardiac fibrosis and inflammation induced by chronic sympathetic activation" [Int. Immunopharmacol. 140 (2024) 112894].

Journal: International immunopharmacology

Published: June 03, 2025

Correction: Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice.

Correction: Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice.

Journal: BMC pulmonary medicine

Published: April 11, 2025

Lapatinib ameliorates skin fibrosis by inhibiting TGF-β1/Smad and non-Smad signaling pathway.

Lapatinib ameliorates skin fibrosis by inhibiting TGF-β1/Smad and non-Smad signaling pathway.

Journal: Scientific reports

Published: December 18, 2024

Multi-omics characterization of early chronic obstructive pulmonary disease.

Multi-omics characterization of early chronic obstructive pulmonary disease.

Journal: Respiratory research

Published: November 02, 2024

Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathway.

Ruxolitinib attenuates bleomycin-induced pulmonary fibrosis in mice by modulating macrophage polarization through the JAK/STAT signaling pathway.

Journal: International immunopharmacology

Published: October 20, 2024

Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Daidzein alleviates skin fibrosis by suppressing TGF-β1 signaling pathway via targeting PKM2.

Journal: Scientific reports

Published: September 29, 2024

Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Miglustat ameliorates isoproterenol-induced cardiac fibrosis via targeting UGCG.

Journal: Molecular medicine (Cambridge, Mass.)

Published: September 12, 2024

Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-β1 Pathway.

Nerandomilast Improves Bleomycin-Induced Systemic Sclerosis-Associated Interstitial Lung Disease in Mice by Regulating the TGF-β1 Pathway.

Journal: Inflammation

Published: August 15, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026